60岁以上老年人肺炎球菌多糖疫苗接种效果分析

Analysis of the effect of pneumococcal polysaccharide vaccination in the aged over 60 years

肺炎球菌感染性疾病主要指肺炎双球菌引起的多种疾病,老年人是感染的高危人群。我国老年人肺炎免疫状况呈现疫苗低接种率、血清抗体低阳性率的状态。在开展免费接种的城市,老年人肺炎疫苗的接种率距发达国家还有一定差距。影响肺炎疫苗接种率的因素,价格是主要制约因素,其次老年人缺乏获取疫苗知识的有效途径和方法,影响了疫苗在老年人群中的使用。23价肺炎球菌多糖疫苗对老年人群具有较好的保护效果,接种后以一般反应和轻度全身反应为主,接种疫苗可降低由肺炎及其并发症导致的医疗费用和劳动生产力损失。在老年人群中应用有较好的经济学价值,可在老年人群中推广使用。

Pneumococcal infectious diseases mainly refer to various diseases caused by diplococcus pneumoniae,the elderly are at high risk of infection.The immunity status of the old people in China shows low vaccination rate and low positive rate of serum antibodies.In cities where free vaccinations are provided,there is still a certain gap on the vaccination rates of older persons against pneumonia between them and developed countries.Among the factors that affect the vaccination rate of pneumonia,price is the main constraint.Secondly,the lack of effective ways and methods to obtain vaccine knowledge among the elderly has affected the use of vaccines in the elderly.The 23-valent pneumococcal polysaccharide vaccine has a good protective effect on the elderly population.General reaction and mild systemic reaction are dominant after inoculation.Vaccination reduces medical costs and labor productivity losses from pneumonia and its complications.It has good economic value in the elderly population,can be widely used in the elderly population.